Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Epilepsy Clinical Trials

101 recruiting trials for Epilepsy. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
101
Total Trials
101
Recruiting Now
9
Phase 3 Trials
10
Sponsors

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGPhase 3NCT07234695

LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome

The purpose of this study is to evaluate whether levetiracetam can prevent epileptic seizures in patients with Alzheimer's disease associated with Down syndrome. It will also...

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauEnrolling: 1205 locations
RECRUITINGPhase 2NCT05104983

Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study

This trial is a Phase II randomized, double-blind, placebo controlled multi-site study to evaluate the safety and efficacy of early sirolimus to prevent or delay seizure onset in...

Sponsor: Darcy KruegerEnrolling: 6411 locations
RECRUITINGNCT06695767

Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder

The purpose of this study is to examine the feasibility and acceptability of an online group Neuro-behavioral Therapy (NBT) with text messaging intervention for Veterans with...

Sponsor: The University of Texas Health Science Center, HoustonEnrolling: 162 locations
RECRUITINGNCT06065852

National Registry of Rare Kidney Diseases

The goal of this National Registry is to is to collect information from patients with rare kidney diseases, so that it that can be used for research. The purpose of this research...

Sponsor: UK Kidney AssociationEnrolling: 350001 location
RECRUITINGNCT06667232

Evaluating Modulation Effects of Burst Stimulation Patterns Using SEEG

The study aims to evaluate modulation effects of burst stimulation patterns via SEEG.

Sponsor: Xuanwu Hospital, BeijingEnrolling: 201 location
RECRUITINGNCT06967935

Sleep and Rehearsal-Driven Memory in Epilepsy

Memory consolidation transforms unstable memory traces into lasting representations, a process enhanced by both sleep and rehearsal during learning. Rehearsal is thought to...

Sponsor: Hospices Civils de LyonEnrolling: 201 location
RECRUITINGNCT00041600

Human Epilepsy Genetics--Neuronal Migration Disorders Study

The purpose of this study is to identify genes responsible for epilepsy, brain malformations and disorders of human cognition.

Sponsor: Harvard University Faculty of MedicineEnrolling: 35001 location
RECRUITINGNCT06380192

Developmental and Epileptic Encephalopathy of Genetic Etiology: Natural History Through Reuse of Clinical Data

Developmental and Epileptic Encephalopathy (DEE) are a heterogeneous group of neurodevelopmental disorders linked to both epilepsy and its underlying etiology, independently of...

Sponsor: Imagine InstituteEnrolling: 40020 locations
RECRUITINGNCT06682299

Maintenance TMS in Treatment Resistant Depression

Electroconvulsive therapy (ECT) is one of the most efficacious treatments available for treatment-resistant depression (TRD). Although a maintenance ECT protocol exists, multiple...

Sponsor: Austin MessnerEnrolling: 301 location
RECRUITINGNCT05664854

Electrical Impedance Tomography & Selective Stimulation of Vagus Nerve

Electroceuticals is a new field in which the goal is to treat a wide variety of medical diseases with electrical stimulation of autonomic nerves. A prime target for intervention...

Sponsor: University College, LondonEnrolling: 501 location
RECRUITINGNCT06292299

The PARS Study: Paediatric Advanced Respiratory Service Study - An Observational Diagnostic Feasibility Study

Diagnostic investigations in paediatric respiratory and sleep medicine are often challenging due to patient size (due to prematurity), tolerability, and compliance with "gold...

Sponsor: NHS Greater Clyde and GlasgowEnrolling: 2252 locations
RECRUITINGNCT06202196

Risk Prevention Program and Therapeutic Patient Education Program of Patients With Uncontrolled Epilepsy

Pilot, controled, randomized study aiming to evaluate a plan for the prevention of risks related to epilepsy, 3 months after the last therapeutic patient education session. Two...

Sponsor: University Hospital, MontpellierEnrolling: 741 location
RECRUITINGNCT06967727

Registry and Natural History of Epilepsy-Dyskinesia Syndromes

The Registry and Natural History of Epilepsy-Dyskinesia Syndromes is focused on gathering longitudinal clinical data as well as biological samples (blood, urine, and/or...

Sponsor: Boston Children's HospitalEnrolling: 7001 location
RECRUITINGPhase 3NCT07490769

Levetiracetam Three Times Daily in Epilepsy

The purpose of this clinical trial is to evaluate the efficacy and tolerability of Levetiracetam administered three times daily in patients with epilepsy. The primary objective is...

Sponsor: Waad AlkathiriEnrolling: 1201 location
RECRUITINGNCT07145489

Infrared Photobiomodulation in Humans With Epilepsy

Drug-resistant epilepsy represents roughly 40% of people with epilepsy. It is very challenging to stop seizures in this condition, and the treatment options are limited. This...

Sponsor: Beth Israel Deaconess Medical CenterEnrolling: 131 location
RECRUITINGNCT00060541

Evaluation and Treatment of Neurosurgical Disorders

Objective: This protocol is designed to allow evaluation of participants neurosurgical disorders that receive care within the Surgical Neurology Branch. The participants will...

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)Enrolling: 50001 location
RECRUITINGNCT01858285

Genetics of Epilepsy and Related Disorders

Investigators at Boston Children's Hospital are conducting research in order to better understand the genetic factors which may contribute to epilepsy and related disorders. These...

Sponsor: Boston Children's HospitalEnrolling: 50001 location
RECRUITINGPhase 3NCT05219617

Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and...

The primary objective is to evaluate the efficacy of carisbamate (YKP509) as adjunctive treatment in reducing the number of drop seizures (tonic, atonic, and tonic-clonic)...

Sponsor: SK Life Science, Inc.Enrolling: 25220 locations
RECRUITINGPhase 1 / Phase 2NCT06609889

A Safety and Efficacy of Intrathecally Administered ION283 in Patients With Lafora Disease

This study will test the safety and efficacy of multiple doses of ION283 administered as intrathecal (IT) injections by lumbar puncture (LP). All subjects will receive ION283. The...

Sponsor: Berge MinassianEnrolling: 101 location
RECRUITINGNCT03233399

Modulating Movement Intention Via Cortical Stimulation

The purpose of this protocol is to learn about movement intention and volition. To improve such knowledge, investigators will conduct sub-studies using multiple non-invasive...

Sponsor: NYU Langone HealthEnrolling: 301 location
RECRUITINGEarly Phase 1NCT06719791

Sirolomus Adjuvant Treatment of Focal Refractory Epilepsy (SATFRE)

The aim of this study is to evaluate the clinical efficacy of sirolimus as an adjunctive therapy for refractory epilepsy. The significance lies in addressing whether the mTOR...

Sponsor: Xuanwu Hospital, BeijingEnrolling: 151 location
RECRUITINGNCT05554835

Global Registry and Natural History Study for Mitochondrial Disorders

The main goal of the project is provision of a global registry for mitochondrial disorders to harmonize previous national registries, enable world-wide participation and...

Sponsor: LMU KlinikumEnrolling: 600018 locations
RECRUITINGPhase 4NCT06346262

Seizure Rescue Medication (RM) as Part of a Comprehensive Epilepsy Self-management Package of Care

This study will be done in two phases. Using stakeholder input (community advisory board (CAB)), the study team will adapt the SMART program to incorporate education and...

Sponsor: University Hospitals Cleveland Medical CenterEnrolling: 302 locations
RECRUITINGNCT06079294

Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism

Prospective cohort study evaluating FDG PET in 56 patients with confirmed autoimmune encephalitis - based on 2016 Graus criteria, and 2021 paraneoplastic neurological syndromes...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 561 location
RECRUITINGPhase 4NCT04144439

Effect of GABA on ADHD and Seizures in Children With Epilepsy.

Effect of GABA on ADHD and seizures in Children with epilepsy.

Sponsor: Sherief Abd-ElsalamEnrolling: 301 location
RECRUITINGNCT05485649

Clinical Outcomes of Pregnant Individuals With Epilepsy - Prospective Study

The aim of this study is to investigate the pregnancy, delivery, neonatal, and epilepsy outcomes in individuals with epilepsy undergoing pregnancy at the Maternal and Infant...

Sponsor: University Health Network, TorontoEnrolling: 801 location
RECRUITINGNCT06944171

Effects of Associated Impairments on Activity and Participation in Children With Cerebral Palsy

This study will investigate the effects of associated impairments on the activity levels and social participation of school-aged children with Cerebral Palsy (aged 6-12) and their...

Sponsor: Hacettepe UniversityEnrolling: 1071 location
RECRUITINGNCT03644732

Atlas of Human Cognition by SEEG (MAPCOG-SEEG)

The main objective of MAPCOG\_SEEG is to create a database including brain recordings of cognition performed in clinical routine in patients during the pre-surgical SEEG...

Sponsor: University Hospital, GrenobleEnrolling: 2004 locations
RECRUITINGNCT05864547

Predisposing Factors for Post-stroke Epilepsy

The goal of this observational study is to learn about epilepsy after a stroke (post-stroke epilepsy). The main questions it aims to answer are: * What make some patients develop...

Sponsor: Norwegian University of Science and TechnologyEnrolling: 301 location
RECRUITINGNCT06782074

Idiopathic Generalized Epilepsy Cognitive and Emotional Profile

The primary goal of the study is to explore the neurocognitive, emotional-behavioral functioning, and quality of life of adolescents with IGE, identifying key factors that affect...

Sponsor: IRCCS National Neurological Institute "C. Mondino" FoundationEnrolling: 961 location
RECRUITINGNCT06623994

Bridging the Treatment Gap by Expanding Access to Care for People With Epilepsy in Kenya (BEACON)

This cluster randomized trial aims to learn about the effectiveness of task-sharing supported by an epilepsy medical records system (EMRS) (hereafter referred to as BEACON) with...

Sponsor: Indiana UniversityEnrolling: 6501 location
RECRUITINGNCT05450822

Precision Medicine in the Treatment of Epilepsy

Primary objectives: The purpose of this study is to identify single and composite biomarkers (from neuroimaging, electrophysiological, and non-imaging biological measures),...

Sponsor: Gitte Moos KnudsenEnrolling: 5501 location
RECRUITINGNCT06598189

Ear-Seizure Detection (EarSD) Study

The proposed study is an investigator-initiated study that aims to measure the accuracy of a wearable seizure detection and prediction device (Ear-Seizure Detection Device...

Sponsor: Felicia ChuEnrolling: 402 locations
RECRUITINGNCT05845255

Evaluation of the Epilepsy-related Quality of Life, Seizure-related Accidents and Validation of the Mjn-SERAS Solution...

The study will be prospective, multicentre, postmarketing clinical study, with a controlled and randomized design, to perform the analysis of 130 subjects with a clinical...

Sponsor: MJN Neuroserveis, S.LEnrolling: 1306 locations
RECRUITINGNCT03478852

Investigating Epilepsy: Screening and Evaluation

Background: Epilepsy affects about 1 percent of the U.S. population. Most people with epilepsy respond well to medicine, but some do not. Researchers want people who have...

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)Enrolling: 10001 location
RECRUITINGNCT06558890

Transcranial Electrical Stimulation Targeting the Cerebellum for the Treatment of Refractory Temporal Lobe Epilepsy

Study the therapeutic effect and potential neural mechanisms of transcranial electrical stimulation targeting the cerebellum for the treatment of refractory temporal lobe epilepsy...

Sponsor: Xijing HospitalEnrolling: 601 location
RECRUITINGNCT05725174

Volatile Non-Invasive Biomarkers of Epileptic Seizures

Breath and sweat samples will be collected from people who have been admitted to hospital after a potential seizure and analysed by the team. The researchers then hope to identify...

Sponsor: University College London HospitalsEnrolling: 2702 locations
RECRUITINGPhase 3NCT07505004

Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures

A multicenter, double-blind, randomized, placebo-controlled clinical trial to evaluate the efficacy and safety of vormatrigine in adults with focal seizures (POWER2)

Sponsor: Praxis Precision MedicinesEnrolling: 3007 locations
RECRUITINGNCT06940089

Invasive Brain-Computer Interfaces for Attention

The goal of this interventional study is to compare if the use of a brain-machine interface (BCI) therapy can improve the symptoms of attentional deficit by producing brain...

Sponsor: University of Texas at AustinEnrolling: 301 location
RECRUITINGEarly Phase 1NCT04649008

Localizing Epileptic Networks Using MRI and iEEG

Upon successful completion of this study, the investigators expect the study's contribution to be the development of noninvasive imaging biomarkers to predict IEEG functional...

Sponsor: University of PennsylvaniaEnrolling: 2901 location
RECRUITINGNCT06022055

Multimodal Study of the Human Brain Epilepsy Tissue

The TIPI2 study is a blood and tissue collection protocol to create an annotated biorepository to support research in drug-resistant epilepsy. The aim of the study will be to...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 1501 location
RECRUITINGNCT06855901

Home Ultra-long Term EEG Monitoring for Rare Epilepsies and Developmental and Epileptic Encephalopathies

With this study the Investigator expects to develop a precise patient-centered model of care by means of home ultra-long-term EEG monitoring with a minimally invasive wearable EEG...

Sponsor: Azienda Ospedaliero-Universitaria di ModenaEnrolling: 304 locations
RECRUITINGPhase 1NCT05032105

The Impact of Focused Ultrasound Thalamotomy of the Anterior Nucleus for Focal-Onset Epilepsy on Anxiety

The purpose of this study is to evaluate the feasibility, safety, and effects on anxiety of high intensity focused ultrasound ablation (FUSA) in patients suffering from...

Sponsor: Ohio State UniversityEnrolling: 101 location
RECRUITINGPhase 2NCT07141329

SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures

This is a Phase 2b open-label extension study to evaluate the long-term safety and efficacy of SPN-817.

Sponsor: Supernus Pharmaceuticals, Inc.Enrolling: 1001 location
RECRUITINGNCT04126369

Impact of Mindfulness Intervention on Quality of Life in Patients With Drug-resistant Epilepsy.

This study evaluates a mindfulness intervention in patients with drug resistant epilepsy. Half of participants will follow a mindfulness programme, while the other half will...

Sponsor: University Hospital, GrenobleEnrolling: 1003 locations
RECRUITINGNCT05927974

Investigating Dynamic Interactions in Distributed Cognitive Control Networks

The purpose of this study is to investigate the brain activity associated with cognitive tasks (thinking, reasoning, remembering) in order to understand how the brain works during...

Sponsor: University of Alabama at BirminghamEnrolling: 301 location
RECRUITINGPhase 2NCT03949478

Treating Postictal Symptoms Using Ibuprofen and Nifedipine

This study will evaluate the effect of ibuprofen or nifedipine on post-seizure hypoperfusion and neurological deficits in patients with epilepsy. One group will receive ibuprofen,...

Sponsor: University of CalgaryEnrolling: 902 locations
RECRUITINGPhase 1NCT02531880

Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy

Background: \- The blood-brain barrier separates the brain from the rest of the body. Epilepsy is a neurological disease that causes seizures. It can affect this barrier....

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)Enrolling: 401 location
RECRUITINGPhase 3NCT04945213

Biperiden Trial for Epilepsy Prevention

One of the most important neurological consequences following Traumatic Brain Injury (TBI) is the development of post traumatic epilepsy (PTE). Nevertheless, there is still no...

Sponsor: Hospital Sirio-LibanesEnrolling: 31210 locations
RECRUITINGPhase 3NCT05667142

A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of XEN1101 administered as...

Sponsor: Xenon Pharmaceuticals Inc.Enrolling: 16020 locations

Showing 50 of 101 trials.Search all Epilepsy trials

Frequently Asked Questions

There are currently 101 clinical trials for Epilepsy, with 101 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Epilepsy, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 9 Phase 3 trials for Epilepsy, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice — always talk to your doctor about clinical trial participation.